Substituted propanamides as inhibitors of nucleases
| Authors | |
|---|---|
| Year of publication | 2022 |
| Type | Patent |
| MU Faculty or unit | |
| Publisher | United States Patent and Trademark Office |
| State | United States of America |
| Patent's number | US11453663 |
| web | https://worldwide.espacenet.com/patent/search?q=pn%3DUS11453663B2 |
| Description | Compounds represented by the structural formula (1) where R1, R2, R3, R4, R5, R6 are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases. |
| Related projects: |